Rat carnitine palmitoyltransferase Iβ mRNA splicing isoforms

被引：12
|
作者：
Yu, GS
Lu, YC
Gulick, T
机构：
[1] Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02129 USA
[2] Massachusetts Gen Hosp, Med Serv, Boston, MA 02129 USA
[3] Harvard Univ, Sch Med, Dept Med, Boston, MA USA
来源：
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM | 1998年 / 1393卷 / 01期
关键词：
carnitine palmitoyltransferase; fatty acid oxidation; mRNA splicing; mitochondrion;
D O I：
10.1016/S0005-2760(98)00075-7
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Carnitine palmitoyltransferase I (CPT-I) catalyzes the rate-determining step in mitochondrial fatty acid beta-oxidation. The enzyme has two cognate structural genes (alpha and beta) that are differentially expressed in tissues. We show multiple mature mRNAs in rat heart derived from alternative splicing of CPT-I beta transcripts. Two novel messages are deleted for regions of the previously described mRNA that encode membrane-spanning and regulatory domains, suggesting that the cognate isozymes will exhibit unique kinetic characteristics. (C) 1998 Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码：166 / 172
页数：7
相关论文
共 50 条
  • [41] Topology of carnitine palmitoyltransferase I in the mitochondrial outer membrane
    Fraser, F
    Corstorphine, CG
    Zammit, VA
    BIOCHEMICAL JOURNAL, 1997, 323 : 711 - 718
  • [42] Complementation analysis of carnitine palmitoyltransferase I and II defects
    Slama, A
    Brivet, M
    Boutron, A
    Legrand, A
    Saudubray, JM
    Demaugre, F
    PEDIATRIC RESEARCH, 1996, 40 (04) : 542 - 546
  • [43] Postoperative coma in a child with carnitine palmitoyltransferase I deficiency
    Neuvonen, PT
    van den Berg, AA
    ANESTHESIA AND ANALGESIA, 2001, 92 (03): : 646 - 647
  • [44] Aminocarnitine Ureidic Derivatives as Inhibitors of Carnitine Palmitoyltransferase I
    Tassoni, Emanuela
    Conti, Roberto
    Gallo, Grazia
    Vincenti, Silvia
    Dell'Uomo, Natalina
    Mastrofrancesco, Lucilla
    Ricciolini, Rita
    Cabri, Walter
    Carminati, Paolo
    Giannessi, Fabio
    CHEMMEDCHEM, 2010, 5 (05) : 666 - 669
  • [45] EVIDENCE FOR DISTINCT FUNCTIONAL MOLECULAR SIZES OF CARNITINE PALMITOYLTRANSFERASE-I AND PALMITOYLTRANSFERASE-II IN RAT-LIVER MITOCHONDRIA
    ZAMMIT, VA
    CORSTORPHINE, CG
    KELLIHER, MG
    BIOCHEMICAL JOURNAL, 1988, 250 (02) : 415 - 420
  • [46] MEASUREMENT OF CARNITINE PALMITOYLTRANSFERASE-I IN HEPATOCYTE MONOLAYERS
    SPURWAY, TD
    AGIUS, L
    SHERRATT, HSA
    POGSON, CI
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1994, 22 (02) : S118 - S118
  • [47] Molecular basis of hepatic carnitine palmitoyltransferase I deficiency
    Ijlst, L
    Mandel, H
    Oostheim, W
    Ruiter, JPN
    Gutman, A
    Wanders, RJA
    JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (03): : 527 - 531
  • [48] Stereoisomeric acylamidomorpholinium carnitine analogues: Selective inhibitors of carnitine palmitoyltransferase I and II
    Savle, PS
    Pande, SV
    Lee, TS
    Gandour, RD
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (21) : 3099 - 3102
  • [49] REGULATION OF CARNITINE PALMITOYLTRANSFERASE-I IN CHICK LIVER
    GRIFFIN, HD
    WINDSOR, D
    ZAMMIT, VA
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1990, 18 (05) : 981 - 982
  • [50] Effects of carnitine palmitoyltransferase I inhibitors on hepatic hypertrophy
    Yotsumoto, T
    Naitoh, T
    Kitahara, M
    Tsuruzoe, N
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 398 (02) : 297 - 302
12345